Aethlon Medical, Inc. Stock Price

NasdaqCM:AEMD Community·US$3.4m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
6 Fair Values set on narratives written by author

Create a narrative

AEMD Share Price Performance

US$4.26

-28.01 (-86.80%)

US$4.26

-28.01 (-86.80%)

US$4.26

Fri, 7 Nov 25

Share PriceUS$4.26

AEMD Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Medium-low risk with excellent balance sheet.

6 Risks

0 Rewards

View Full Analysis

Aethlon Medical, Inc. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -16.52
: 0%
: 0%
: 3.3%

View Full Analysis

About AEMD

Founded: 1984
Employees: 9
CEO: James Frakes
WebsiteView website: www.aethlonmedical.com

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Recent AEMD News & Updates

Recent updates

No updates

Aethlon Medical, Inc. Competitors

Aethlon Medical, Inc. Stock Price

AEMD Share Price Performance

AEMD Community Narratives

Snowflake Analysis

Aethlon Medical, Inc. Key Details

About AEMD

Recent AEMD News & Updates

Aethlon Medical, Inc. Receives Letter from Nasdaq for Non-Compliance to Continued Listing

Aethlon Medical, Inc. Provides Observations on the Preliminary Changes in Extracellular Vesicle (EV), MicroRNA and Lymphocyte Counts in the First Patient Cohort in its Ongoing Oncology Clinical Trial in Australia

Aethlon Medical, Inc. has withdrawn its Follow-on Equity Offering.

Recent updates

Aethlon Medical, Inc. Competitors

Welsis

Vycor Medical

Fuse Medical

Inspire Veterinary Partners